UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Marten Transport L (MRTN)

Marten Transport L (MRTN)
13.21 -0.25 (-1.86%) 14:12 ET [NASDAQ]
13.19 x 34 13.23 x 152
Realtime by (Cboe BZX)
13.19 x 34 13.23 x 152
Realtime 13.00 -0.46 (-3.42%) 05:48 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
13.01
Day High
13.40
Open 13.23
Previous Close 13.46 13.46
Volume 188,262 188,262
Avg Vol 483,816 483,816
Stochastic %K 37.25% 37.25%
Weighted Alpha -28.43 -28.43
5-Day Change -0.07 (-0.50%) -0.07 (-0.50%)
52-Week Range 12.52 - 19.26 12.52 - 19.26
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,096,519
  • Shares Outstanding, K 81,465
  • Annual Sales, $ 963,710 K
  • Annual Income, $ 26,920 K
  • EBIT $ 145 M
  • EBITDA $ 257 M
  • 60-Month Beta 1.01
  • Price/Sales 1.07
  • Price/Cash Flow 7.46
  • Price/Book 1.35

Options Overview Details

View History
  • Implied Volatility 60.64% ( +9.02%)
  • Historical Volatility 30.17%
  • IV Percentile 87%
  • IV Rank 63.70%
  • IV High 91.12% on 09/25/24
  • IV Low 7.13% on 05/17/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 364
  • Put/Call OI Ratio 1.18
  • Today's Open Interest 8,434
  • Open Int (30-Day) 6,564

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.52 +4.90%
on 04/09/25
Period Open: 14.35
14.42 -8.92%
on 03/11/25
-1.22 (-8.47%)
since 03/10/25
3-Month
12.52 +4.90%
on 04/09/25
Period Open: 15.26
16.95 -22.51%
on 01/28/25
-2.13 (-13.93%)
since 01/10/25
52-Week
12.52 +4.90%
on 04/09/25
Period Open: 17.22
19.26 -31.81%
on 07/31/24
-4.09 (-23.73%)
since 04/10/24

Most Recent Stories

More News
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND

MRTN : 13.21 (-1.86%)
Marten Transport Announces Fourth Quarter and Year End Results

MRTN : 13.21 (-1.86%)
Marten Transport Declares Quarterly Cash Dividend of $0.06 per Share

Marten Transport declared a quarterly dividend of $0.06 per share, marking its 58th consecutive dividend payment.Quiver AI SummaryMarten Transport, Ltd. announced a quarterly cash dividend of $0.06 per...

MRTN : 13.21 (-1.86%)
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND

MRTN : 13.21 (-1.86%)
Insider Purchase: Director at Marten Transport (MRTN) Buys 10,000 Shares

JERRY M BAUER, a director at Marten Transport ($MRTN), bought 10,000 shares of the company on 10-30-2024. We received data on the trade from a recent SEC filing. This increased their holdings by approximately...

MRTN : 13.21 (-1.86%)
Marten Transport Announces Third Quarter Results

MRTN : 13.21 (-1.86%)
Marten’s earnings reflect weaker truckload market 

Truckload carrier Marten saw its earnings fall from a year ago and detailed how much of that was caused by higher fuel prices.  The post Marten’s earnings reflect weaker truckload market  appeared...

MRTN : 13.21 (-1.86%)
Stocks Fall and Bond Yields Climb as Fed Remains Hawkish

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Wednesday closed down -0.76%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,270.23 (-3.42%)
SPY : 522.09 (-4.84%)
$DOWI : 39,646.98 (-2.37%)
DIA : 393.40 (-3.12%)
$IUXX : 18,359.55 (-4.10%)
QQQ : 443.73 (-4.78%)
JKHY : 170.24 (-0.28%)
AMD : 86.75 (-10.42%)
MRVL : 53.12 (-12.86%)
NXPI : 164.32 (-11.59%)
ADI : 175.74 (-10.62%)
GFS : 33.61 (-7.10%)
Marten sees minor pullback from Q1, sharper drop from a year ago

With sequential comparisons as important as year on year, truckload carrier Marten held on in Q2 compared to Q1. The post Marten sees minor pullback from Q1, sharper drop from a year ago appeared first...

MRTN : 13.21 (-1.86%)
WERN : 28.18 (-2.12%)
HTLD : 8.56 (-2.17%)
Stocks Settle Mixed on Weak U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 5,270.23 (-3.42%)
SPY : 522.09 (-4.84%)
$DOWI : 39,646.98 (-2.37%)
DIA : 393.40 (-3.12%)
$IUXX : 18,359.55 (-4.10%)
QQQ : 443.73 (-4.78%)
INTC : 19.60 (-8.96%)
GFS : 33.61 (-7.10%)
MRVL : 53.12 (-12.86%)
QCOM : 133.09 (-7.31%)
MCHP : 38.28 (-14.74%)
MU : 69.35 (-10.94%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Provides Company Update and Anticipated Development Milestones for 2025

EYPT : 4.54 (-0.66%)
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors

EYPT : 4.54 (-0.66%)
EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUCIA Trial for DURAVYU in Wet AMD

EyePoint Pharmaceuticals initiates LUCIA trial for DURAVYU, evaluating efficacy in wet AMD with data expected in 2026.Quiver AI SummaryEyePoint Pharmaceuticals announced that the first patient has been...

EYPT : 4.54 (-0.66%)
EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals: Q3 Earnings Snapshot

EyePoint Pharmaceuticals: Q3 Earnings Snapshot

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Provides Company Update and Anticipated Development Milestones for 2025

EYPT : 4.54 (-0.66%)
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors

EYPT : 4.54 (-0.66%)
EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Doses First Patient in Phase 3 LUCIA Trial for DURAVYU in Wet AMD

EyePoint Pharmaceuticals initiates LUCIA trial for DURAVYU, evaluating efficacy in wet AMD with data expected in 2026.Quiver AI SummaryEyePoint Pharmaceuticals announced that the first patient has been...

EYPT : 4.54 (-0.66%)
EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals: Q3 Earnings Snapshot

EyePoint Pharmaceuticals: Q3 Earnings Snapshot

EYPT : 4.54 (-0.66%)
EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

EYPT : 4.54 (-0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Marten Transport, Ltd. is a long-haul truckload carrier providing protective service and time- sensitive transportation in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment....

See More

Key Turning Points

3rd Resistance Point 14.95
2nd Resistance Point 14.27
1st Resistance Point 13.87
Last Price 13.21
1st Support Level 12.79
2nd Support Level 12.11
3rd Support Level 11.71

See More

52-Week High 19.26
Fibonacci 61.8% 16.69
Fibonacci 50% 15.89
Fibonacci 38.2% 15.09
Last Price 13.21
52-Week Low 12.52

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.